Catalyst Wire Dossier Catalyst Wire Dossier

Anti-siglec-6 CAR-T Cell Therapy

CAR-T directed at Siglec-6 · Xuzhou Medical University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-siglec-6 CAR-T Cell Therapy, covering 2022-08-04 to 2022-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML) [Phase 1, Phase 2]

See pricing